HeartBeam (BEATW) Stock Price, News & Analysis

Company Overview

HeartBeam, Inc. is a clinical-stage medical technology company focused on transforming the diagnosis of acute cardiac events through innovative electrocardiogram (ECG) solutions. The company’s core offering leverages proprietary VectorBEAM™ technology to reconstruct a full 12-lead ECG from a compact, three-lead wearable or handheld device. By enabling rapid acquisition and secure transmission of high-fidelity ECG data, HeartBeam’s approach aims to expedite the detection of myocardial ischemia in out-of-hospital settings.

HeartBeam’s product ecosystem combines hardware, mobile applications, and cloud-based analytics. The wearable or handheld form factor is designed for use by patients, first responders, and telehealth providers, facilitating real-time triage and remote consultation with cardiovascular specialists. The accompanying software platform supports automated comparisons of current readings against patient-specific baseline ECGs, enhancing the accuracy of ischemia detection and reducing reliance on subjective interpretation.

Based in Santa Monica, California, HeartBeam is conducting clinical studies to validate its technology in collaboration with leading medical centers and emergency medical services organizations across the United States. The company’s regulatory strategy has included submissions to the U.S. Food and Drug Administration and engagements with European health authorities in anticipation of broader market access. HeartBeam’s leadership team combines experience in medical device development, cardiovascular clinical research, and digital health commercialization, positioning the company to address critical gaps in early heart attack diagnosis and remote patient monitoring.

Key Stats

• Today's Range: $0.24 to $0.26
• 50-Day Range: $0.23 to $0.37
• 52-Week Range: $0.20 to $0.95
• Volume: 12,017 shs
• Average Volume: 11,636 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

BEATW Stock Analysis - Frequently Asked Questions

How have BEATW shares performed this year?

HeartBeam's stock was trading at $0.6486 on January 1st, 2025. Since then, BEATW stock has decreased by 59.6% and is now trading at $0.2620.

How do I buy shares of HeartBeam?

Shares of BEATW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Health Information Services
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:BEATW
• CIK: 1779372
• Web: www.heartbeam.com
• Phone: 408-899-4443
• Fax: N/A
• Employees: 5
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A